During the 2022-23 and 2024-25 flu seasons, the incidence of cardiorespiratory hospitalization was 2.25% in the high-dose group and 2.38% in the standard-dose group.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) Pandemic flu activity in the United States stayed level for the fourth week in a row, though the US Centers for Disease Control and Prevention (CDC) reported slight increases in the number of outpatient visits for flu-like illnesses and deaths from pneumonia and influenza.
(CIDRAP News) For the third week in a row pandemic flu activity stayed at the same level, with mixed signals from other indicators: flu and pneumonia deaths dropped below baseline, though doctor visits for flulike illnesses were above baselines in three regions, the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) Pandemic flu activity last week stayed level with the previous week, though the virus continues to circulate and cause deaths, prompting a warning from the US Centers for Disease Control and Prevention (CDC) that Americans shouldn't let their guard down.
(CIDRAP News) Fine-tuning pandemic communications strategies relating to children's issues can help avoid problems that doctors and hospitals experienced during surges of novel H1N1 flu, the US Centers for Disease Control and Prevention (CDC) said today in new guidance.
